References
- Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360(9344):1489–1497.
- ACOG Committee on Practice Bulletins--Obstetrics. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynecol Obstet. 2003;82(1):127–135.
- Institute of Medicine. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press; 2007.
- Lucovnik M, Chambliss LR, Garfield RE. Costs of unnecessary admissions and treatments for “threatened preterm labor”. Am J Obstet Gynecol. 2013;209(3):217.e1–217.e3.
- McPheeters ML, Miller WC, Hartmann KE, et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol. 2005;192(4):1325–9; discussion 1329.
- Iams JD, Casal D, McGregor JA, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol. 1995;173(1):141–145.
- Sotiriadis A, Papatheodorou S, Kavvadias A, et al. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol. 2010;35(1):54–64.
- Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol. 1997;177(1):13–18.
- Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol. 2016;215(4):431–438.
- Macones GA. Fetal fibronectin testing in threatened preterm labor: a time to stop. Am J Obstet Gynecol. 2016;215(4):405.
- Abbott DS, Radford SK, Seed PT, et al. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol. 2013;208(2):122.e1–122.e6.
- Bruijn M, Vis JY, Wilms FF, et al. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women. BJOG. 2016;123(12):1965–1971.
- Nikolova T, Bayev O, Nikolova N, et al. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J Perinat Med. 2014;42(4):473–477.
- Nikolova T, Bayev O, Nikolova N, et al. Comparison of a novel test for placental alpha macroglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015;43(4):395–402.
- Bolotskikh V, Borisova V. Combined value of placental alpha microglobulin-1 detection and cervical length via transvaginal ultrasound in the diagnosis of preterm labor in symptomatic patients. J Obstet Gynaecol Res. 2017;43(8):1263–1269.
- Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44(8):763–770.
- von Schöning D, Fischer T, von Tucher E, et al. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test. J Perinat Med. 2015;43(5):531–536.
- Riboni F, Vitulo A, Dell’avanzo M, et al. Biochemical markers predicting preterm delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin. Arch Gynecol Obstet. 2011;284(6):1325–1329.
- Werlen S, Raia T, Di Bartolomeo A, et al. Preterm labor: reproducibility of detection test of PAMG-1 before and after digital examination, and transvaginal ultrasound cervical length. Gynecol Obstet Fertil. 2015;43(10):640–645. [article in French].